265 related articles for article (PubMed ID: 10398124)
1. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.
Bartkova J; Lukas J; Strauss M; Bartek J
Oncogene; 1998 Aug; 17(8):1027-37. PubMed ID: 9747882
[TBL] [Abstract][Full Text] [Related]
3. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
Bartkova J; Lukas J; Müller H; Strauss M; Gusterson B; Bartek J
Cancer Res; 1995 Feb; 55(4):949-56. PubMed ID: 7850812
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis.
Sicinski P; Donaher JL; Geng Y; Parker SB; Gardner H; Park MY; Robker RL; Richards JS; McGinnis LK; Biggers JD; Eppig JJ; Bronson RT; Elledge SJ; Weinberg RA
Nature; 1996 Dec; 384(6608):470-4. PubMed ID: 8945475
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of expression of the D-type cyclins during testicular development in the mouse.
Ravnik SE; Rhee K; Wolgemuth DJ
Dev Genet; 1995; 16(2):171-8. PubMed ID: 7537638
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D3 expression in normal, reactive and neoplastic tissues.
Doglioni C; Chiarelli C; Macrí E; Dei Tos AP; Meggiolaro E; Dalla Palma P; Barbareschi M
J Pathol; 1998 Jun; 185(2):159-66. PubMed ID: 9713342
[TBL] [Abstract][Full Text] [Related]
7. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.
Wong SC; Chan JK; Lee KC; Hsiao WL
J Pathol; 2001 May; 194(1):35-42. PubMed ID: 11329139
[TBL] [Abstract][Full Text] [Related]
10. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.
Pirkmaier A; Dow R; Ganiatsas S; Waring P; Warren K; Thompson A; Hendley J; Germain D
Oncogene; 2003 Jul; 22(28):4425-33. PubMed ID: 12853979
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
Geum D; Sun W; Paik SK; Lee CC; Kim K
Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
[TBL] [Abstract][Full Text] [Related]
12. Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells.
Preclíková H; Bryja V; Pacherník J; Krejcí P; Dvorák P; Hampl A
Cell Growth Differ; 2002 Sep; 13(9):421-30. PubMed ID: 12354751
[TBL] [Abstract][Full Text] [Related]
13. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
14. Critical role for D-type cyclins in cellular transformation induced by E6/E7 of human papillomavirus type 16 and E6/E7/ErbB-2 cooperation.
Yasmeen A; Hosein AN; Yu Q; Al Moustafa AE
Cancer Sci; 2007 Jul; 98(7):973-7. PubMed ID: 17489986
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
16. G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation.
Wianny F; Real FX; Mummery CL; Van Rooijen M; Lahti J; Samarut J; Savatier P
Dev Dyn; 1998 May; 212(1):49-62. PubMed ID: 9603423
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
18. Crucial roles of D-type cyclins in the early stage of adipocyte differentiation.
Hishida T; Naito K; Osada S; Nishizuka M; Imagawa M
Biochem Biophys Res Commun; 2008 May; 370(2):289-94. PubMed ID: 18374658
[TBL] [Abstract][Full Text] [Related]
19. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
